Digital animal free testing (daft) system
AssigneeTranscell Oncologics Private Limited
InventorsSubhadra Dravida, Samhita B L N
Life of this patent
Estimating the term…
Loading patent…
AssigneeTranscell Oncologics Private Limited
InventorsSubhadra Dravida, Samhita B L N
Estimating the term…
The present invention discloses a workstation solution for test predicting human safety concerns and efficacy measurements in a test agent. The workstation solution comprises, a real-time platform or human MicroPhysiological Systems (hMPS) unit, and a digital platform. The digital platform with embedded artificial intelligence (AI) is configured to predict safety (pharmacology) risks from phenotypes, genotypes and proteotype data sets acquired from test agents treated hMPS platform in a modular assay system. The digital platform is trained with phenotypes, genotypes, proteotypes, biochemical data sets as benchmark patterns and signals configured as positive or negative controls to provide a bandwidth to AI for detecting anomalies in a real-time assaying and for measuring the analyzed insights in real-time assaying. The workstation solution is a Digital Animal Free Testing (DAFT), which is a foundational scheme while the modular assay system is one of a derived application.
A workstation solution for test predicting human safety concerns in a test agent, comprising:
A workstation solution for test predicting efficacy measurements in a test agent, comprising:
Dependencies are inferred from the claim text.